You just read:

A New Review of Real-world Experiences of Fluocinolone Acetonide (0.2 μg/day) Intravitreal Implant in the Treatment of Diabetic Macular Oedema

News provided by

touchOPHTHALMOLOGY.com

15 Oct, 2015, 13:00 BST